The global targeted therapeutics market is experiencing significant growth, driven by increasing cancer cases and a surge in product approvals. This market is expected to reach US$ 118.6 Billion by 2034, driven by a 6.4% CAGR. The report highlights the rise of precision medicine and the potential of targeted therapies in treating autoimmune and inflammatory diseases.